Proponents of GLP-1 agonists highlight the drugs effectiveness in curbing appetite and promoting weight loss, while opponents argue the drugs come with serious side effects and cost too much to make a dent in the obesity crisis
Gaskins AJ, Afeiche MC, Wright DL, Toth TL, Williams PL, Gillman MW, et al
P., McHill, A
At baseline, 57% of the patients were women, with a mean age of 62.8 (SD 12.1) years
Researchers in Denmark explored this question in a clinical trial involving adults with both obesity and alcohol use disorder
In most studies, the adverse events did not lead to treatment discontinuation (12, 19, 21, 22, 2433)